Resistance to Octreotide LAR in Acromegalic Patients With High SSTR2 Expression: Analysis of AIP Expression

Arquivos Brasileiros de Endocrinologia & Metabologia
doi 10.1590/s0004-27302012000800007
Full Text
Abstract

Available in full text

Date
Authors
Publisher

FapUNIFESP (SciELO)

Related search

Molecular Analysis of miRNA Expression Profiles in AIP Mutation Positive Somatotropinomas

Endocrine Abstracts
2015English

Octreotide LAR Dosage and Survival Among Elderly Patients With Distant-Stage Neuroendocrine Tumors

Oncologist
Cancer ResearchMedicineOncology
2016English

Lanreotide vs Octreotide LAR for Patients With Advanced Gastroenteropancreatic Neuroendocrine Tumors: An Observational Time and Motion Analysis

Journal of Oncology Pharmacy Practice
MedicineOncologyPharmacology
2019English

Change in Quality of Life in Patients With Acromegaly After Treatment With Octreotide LAR: First Application of AcroQoL in Korea

BMJ Open
Medicine
2015English

Combined Treatment With Octreotide LAR and Pegvisomant in Patients With Gigantism - Acromegaly: Clinical Evaluation and Genetic Screening

Endocrine Abstracts
2016English

Octreotide LAR Was Useful for Avoiding Hypoglycemia in an Elderly Patient With Insulinoma

Japanese Journal of Geriatrics
GerontologyGeriatrics
2017English

High CD74 Expression Correlates With ZAP70 Expression in B Cell Chronic Lymphocytic Leukemia Patients

Medical Oncology
MedicineCancer ResearchOncologyHematology
2013English

Outcome Melatonin Supplementation on Insulin Resistance in a Sample of Iraqi Acromegalic Patients With Sleep Apnea

Al Mustansiriyah Journal of Pharmaceutical Sciences
2019English

Teste Agudo Com Octreotide Subcutâneo Como Preditor De Resposta Ao Tratamento Com Octreotide LAR®

Arquivos Brasileiros de Endocrinologia & Metabologia
2005English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy